Research ArticleCancer

Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies

See allHide authors and affiliations

Science Translational Medicine  12 Feb 2020:
Vol. 12, Issue 530, eaax0876
DOI: 10.1126/scitranslmed.aax0876

Article Information

vol. 12 no. 530

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication March 1, 2019
  • Resubmitted October 25, 2019
  • Accepted for publication January 13, 2020
  • .

Author Information

  1. Candice R. Gurbatri1,
  2. Ioana Lia1,
  3. Rosa Vincent1,
  4. Courtney Coker1,
  5. Samuel Castro1,
  6. Piper M. Treuting2,
  7. Taylor E. Hinchliffe1,
  8. Nicholas Arpaia3,4 and
  9. Tal Danino1,4,5,*
  1. 1Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
  2. 2Department of Comparative Medicine, University of Washington, Seattle, WA 98195, USA.
  3. 3Department of Microbiology & Immunology, Vagelos College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.
  4. 4Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10027, USA.
  5. 5Data Science Institute, Columbia University, New York, NY 10027, USA.
  1. *Corresponding author. Email: td2506{at}columbia.edu

Altmetric

Article usage

Article usage: February 2020 to July 2020

AbstractFullPdf
Feb 2020966319691060
Mar 20201571407357
Apr 2020888184192
May 2020766184142
Jun 2020292306193
Jul 2020613357

Stay Connected to Science Translational Medicine

Navigate This Article